DOCSLIB.ORG

Infectious Diseases of Brazil

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Infectious Diseases of Brazil INFECTIOUS DISEASES OF BRAZIL Stephen Berger, MD Infectious Diseases of Brazil - 2013 edition Infectious Diseases of Brazil - 2013 edition Stephen Berger, MD Copyright © 2013 by GIDEON Informatics, Inc. All rights reserved. Published by GIDEON Informatics, Inc, Los Angeles, California, USA. www.gideononline.com Cover design by GIDEON Informatics, Inc No part of this book may be reproduced or transmitted in any form or by any means without written permission from the publisher. Contact GIDEON Informatics at [email protected]. ISBN-13: 978-1-61755-449-0 ISBN-10: 1-61755-449-9 Visit http://www.gideononline.com/ebooks/ for the up to date list of GIDEON ebooks. DISCLAIMER: Publisher assumes no liability to patients with respect to the actions of physicians, health care facilities and other users, and is not responsible for any injury, death or damage resulting from the use, misuse or interpretation of information obtained through this book. Therapeutic options listed are limited to published studies and reviews. Therapy should not be undertaken without a thorough assessment of the indications, contraindications and side effects of any prospective drug or intervention. Furthermore, the data for the book are largely derived from incidence and prevalence statistics whose accuracy will vary widely for individual diseases and countries. Changes in endemicity, incidence, and drugs of choice may occur. The list of drugs, infectious diseases and even country names will vary with time. Scope of Content: Disease designations may reflect a specific pathogen (ie, Adenovirus infection), generic pathology (Pneumonia - bacterial) or etiologic grouping (Coltiviruses - Old world). Such classification reflects the clinical approach to disease allocation in the Infectious Diseases Module of the GIDEON web application. Similarly, a number of diseases which are generally diagnosed and treated outside of the field of Infectious Diseases are not included, despite the fact that a clear infectious etiology exists. Examples include Peptic ulcer, Tropical spastic paraparesis, Hairy-cell leukemia, Creutzfeldt-Jakob disease, Human papilloma virus infections, etc. In contrast, a number of other entities of unknown etiology which do present to Infectious Diseases specialists have been included: Kawasaki's disease, Chronic fatigue syndrome, Kikuchi and Kimura diseases. Several minor infections having minimal relevance to the field of Geographic Medicine are not covered: Paronychia, Otitis externa, Molluscum contagiosum, etc. © 2013 GIDEON Informatics, Inc. www.gideononline.com All Rights Reserved. Page 1 of 580 Infectious Diseases of Brazil - 2013 edition Introduction: The GIDEON e-book series Infectious Diseases of Brazil is one in a series of GIDEON ebooks which summarize the status of individual infectious diseases, in every country of the world. Data are based on the GIDEON web application (www.gideononline.com) which relies on standard text books, peer-review journals, Health Ministry reports and ProMED, supplemented by an ongoing search of the medical literature. Chapters are arranged alphabetically, by disease name. Each section is divided into four sub-sections: 1. Descriptive epidemiology 2. Summary of clinical features 3. Status of the disease in Brazil 4. References The initial items in the first section, Descriptive epidemiology, are defined as follows: Agent Classification (e.g., virus, parasite) and taxonomic designation. Reservoir Any animal, arthropod, plant, soil or substance in which an infectious agent normally lives and multiplies, on which it depends primarily for survival, and where it reproduces itself in such a manner that it can be transmitted to a susceptible host. Vector An arthropod or other living carrier which transports an infectious agent from an infected organism or reservoir to a susceptible individual or immediate surroundings. Vehicle The mode of transmission for an infectious agent. This generally implies a passive and inanimate (i.e., non-vector) mode. There are 348 generic infectious diseases in the world today. 251 of these are endemic, or potentially endemic, to Brazil. A number of other diseases are not relevant to Brazil and have not been included in this book. In addition to endemic diseases, we have included all published data regarding imported diseases and infection among expatriates from Brazil. The availability and quality of literature regarding specific infectious diseases vary from country to country. As such, you may find that many of the sections in this book are limited to a general discussion of the disease itself - with no data regarding Brazil. This is a book about the geography and epidemiology of Infection. Comprehensive and up-to-date information regarding the causes, diagnosis and treatment of each disease is available in the GIDEON web application. Many of the diseases are generic. For example, such designations as Pneumonia bacterial and Urinary tract infection include a number of individual diseases. These appear under the subheading, Synonyms, listed under each disease. We welcome feedback, and will be pleased to add any relevant, sourced material. Email us at [email protected] For more information about GIDEON see the section About GIDEON and visit www.gideononline.com Last updated: February 19, 2013 © 2013 GIDEON Informatics, Inc. www.gideononline.com All Rights Reserved. Page 2 of 580 Infectious Diseases of Brazil - 2013 edition Table of Contents Introduction: The GIDEON e-book series ......................... 2 Common cold+ .......................................................... 106 Actinomycosis .............................................................. 6 Conjunctivitis - inclusion............................................. 107 Adenovirus infection+.................................................... 8 Conjunctivitis - viral+ ................................................. 108 Aeromonas & marine Vibrio infx.+................................. 11 Cryptococcosis+ ........................................................ 109 African tick bite fever* ................................................ 13 Cryptosporidiosis+ ..................................................... 112 AIDS+....................................................................... 15 Cutaneous larva migrans+ .......................................... 114 Amoeba - free living+.................................................. 24 Cyclosporiasis+ ......................................................... 116 Amoebic abscess+ ...................................................... 26 Cysticercosis+ ........................................................... 117 Amoebic colitis+ ......................................................... 27 Cytomegalovirus infection+ ......................................... 120 Anaplasmosis* ........................................................... 30 Dengue+ .................................................................. 123 Angiostrongyliasis+ ..................................................... 32 Dermatophytosis+ ..................................................... 132 Angiostrongyliasis - abdominal+ ................................... 34 Dicrocoeliasis............................................................ 133 Animal bite-associated infection ................................... 36 Dientamoeba fragilis infection+ ...................................134 Anisakiasis+............................................................... 37 Dioctophyme renalis infection+....................................135 Anthrax+ ................................................................... 39 Diphtheria+ .............................................................. 136 Ascariasis+ ................................................................ 44 Diphyllobothriasis+ .................................................... 140 Aspergillosis+............................................................. 47 Dipylidiasis+ ............................................................. 141 Babesiosis*................................................................ 49 Dirofilariasis+............................................................ 142 Bacillary angiomatosis+ ............................................... 51 Eastern equine encephalitis+....................................... 144 Bacillus cereus food poisoning+ .................................... 52 Echinococcosis - American polycystic+..........................146 Bacterial vaginosis+ .................................................... 54 Echinococcosis - unilocular+........................................ 148 Balantidiasis .............................................................. 56 Ehrlichiosis - human monocytic+..................................150 Bartonellosis - cat borne+ ............................................ 57 Endocarditis - infectious ............................................. 152 Bartonellosis - other systemic+..................................... 59 Enterobiasis+ ............................................................ 153 Bertiella and Inermicapsifer ......................................... 61 Enterovirus infection+ ................................................ 155 + Blastocystis hominis infection ..................................... 62 Entomophthoramycosis+ ............................................ 158 Botulism+ .................................................................. 64 Epidural abscess ....................................................... 160 Brain abscess............................................................
Load more

Recommended publications
  • Melioidosis: an Emerging Infectious Disease
    Review Article www.jpgmonline.com Melioidosis: An emerging infectious disease Raja NS, Ahmed MZ,* Singh NN** Department of Medical ABSTRACT Microbiology, University of Malaya Medical Center, Kuala Lumpur, Infectious diseases account for a third of all the deaths in the developing world. Achievements in understanding Malaysia, *St. the basic microbiology, pathogenesis, host defenses and expanded epidemiology of infectious diseases have Bartholomew’s Hospital, resulted in better management and reduced mortality. However, an emerging infectious disease, melioidosis, West Smithfield, London, is becoming endemic in the tropical regions of the world and is spreading to non-endemic areas. This article UK and **School of highlights the current understanding of melioidosis including advances in diagnosis, treatment and prevention. Biosciences, Cardiff Better understanding of melioidosis is essential, as it is life-threatening and if untreated, patients can succumb University, Cardiff, UK to it. Our sources include a literature review, information from international consensus meetings on melioidosis Correspondence: and ongoing discussions within the medical and scientific community. N. S. Raja, E-mail: [email protected] Received : 21-2-2005 Review completed : 20-3-2005 Accepted : 30-5-2005 PubMed ID : 16006713 KEY WORDS: Melioidosis, Burkholderia pseudomallei, Infection J Postgrad Med 2005;51:140-5 he name melioidosis [also known as Whitmore dis- in returning travellers to Europe from endemic areas.[14] The T ease] is taken from the Greek word ‘melis’ meaning geographic area of the prevalence of the organism is bound to distemper of asses and ‘eidos’ meaning resembles glanders. increase as the awareness increases. Melioidosis is a zoonotic disease caused by Pseudomonas pseudomallei [now known as Burkholderia pseudomallei], a B.
    [Show full text]
  • 537 Evapotranspiração De Referência Pelo
    Irriga, Botucatu, v. 25, n. 3, p. 537-548, julho-setembro, 2020 537 ISSN 1808-8546 (ONLINE) 1808-3765 (CD-ROM) EVAPOTRANSPIRAÇÃO DE REFERÊNCIA PELO MÉTODO DE PENMAN- MONTEITH EM ANOS DE ENOS PARA MICRORREGIÃO DE PELOTAS-RS LUKAS DOS SANTOS BOEIRA¹; MICHAELA BÁRBARA NETO²; LÚCIO DE ARAÚJO NEVES3; VIVIANE SANTOS SILVA TERRA4 E GILBERTO LOGUERCIO COLLARES4 1Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Rua Gomes Carneiro, n° 1, Balsa, 96010-610, Pelotas, Rio Grande do Sul, Brasil, [email protected] 2Departamento de Engenharia de Biossistemas, Universidade de São Paulo, Escola Superior de Agricultura “Luiz de Queiroz”, Av. Pádua Dias, 11, Caixa Postal 09, 13416-000, Piracicaba, São Paulo, Brasil, [email protected] 3Departamento de Solos, Instituto Federal Sul-Rio-Grandense, Campus Pelotas - Visconde da Graça, Avenida Engenheiro Ildefonso Simões Lopes, Três Vendas, 96060-290, Pelotas, Rio Grande do Sul, Brasil, [email protected] 4Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Rua Gomes Carneiro, n° 1, Balsa, 96010-610, Pelotas, Rio Grande do Sul, Brasil, [email protected]; [email protected] 1 RESUMO A Microrregião de Pelotas, localizada no Sudeste do Rio Grande do Sul é uma das maiores produtoras de arroz irrigado do Brasil. A produção de arroz na região é realizada através do sistema de irrigação por inundação. Um dos fatores que influência na altura da lâmina d'água no sistema é a evapotranspiração, a qual está diretamente relacionada aos elementos e fenômenos climáticos. O El Niño Oscilação Sul (ENOS) é um dos principais fenômenos climáticos na região. O objetivo do estudo foi avaliar se a evapotranspiração de referência (ET0) é afetada pelos períodos de ENOS na Microrregião de Pelotas-RS.
    [Show full text]
  • Cutaneous Manifestations of HIV Infection Carrie L
    Chapter Title Cutaneous Manifestations of HIV Infection Carrie L. Kovarik, MD Addy Kekitiinwa, MB, ChB Heidi Schwarzwald, MD, MPH Objectives Table 1. Cutaneous manifestations of HIV 1. Review the most common cutaneous Cause Manifestations manifestations of human immunodeficiency Neoplasia Kaposi sarcoma virus (HIV) infection. Lymphoma 2. Describe the methods of diagnosis and treatment Squamous cell carcinoma for each cutaneous disease. Infectious Herpes zoster Herpes simplex virus infections Superficial fungal infections Key Points Angular cheilitis 1. Cutaneous lesions are often the first Chancroid manifestation of HIV noted by patients and Cryptococcus Histoplasmosis health professionals. Human papillomavirus (verruca vulgaris, 2. Cutaneous lesions occur frequently in both adults verruca plana, condyloma) and children infected with HIV. Impetigo 3. Diagnosis of several mucocutaneous diseases Lymphogranuloma venereum in the setting of HIV will allow appropriate Molluscum contagiosum treatment and prevention of complications. Syphilis Furunculosis 4. Prompt diagnosis and treatment of cutaneous Folliculitis manifestations can prevent complications and Pyomyositis improve quality of life for HIV-infected persons. Other Pruritic papular eruption Seborrheic dermatitis Overview Drug eruption Vasculitis Many people with human immunodeficiency virus Psoriasis (HIV) infection develop cutaneous lesions. The risk of Hyperpigmentation developing cutaneous manifestations increases with Photodermatitis disease progression. As immunosuppression increases, Atopic Dermatitis patients may develop multiple skin diseases at once, Hair changes atypical-appearing skin lesions, or diseases that are refractory to standard treatment. Skin conditions that have been associated with HIV infection are listed in Clinical staging is useful in the initial assessment of a Table 1. patient, at the time the patient enters into long-term HIV care, and for monitoring a patient’s disease progression.
    [Show full text]
  • Bacterial Soft Tissue Infections Following Water Exposure
    CHAPTER 23 Bacterial Soft Tissue Infections Following Water Exposure Sara E. Lewis, DPM Devin W. Collins, BA Adam M. Bressler, MD INTRODUCTION to early generation penicillins and cephalosporins. Thus, standard treatments include fluoroquinolones (ciprofloxacin, Soft tissue infections following water exposure are relatively levofloxacin), third and fourth generation cephalosporins uncommon but can result in high morbidity and mortality. (ceftazidime, cefepime), or potentially trimethoprim-sulfa These infections can follow fresh, salt, and brackish water (4). However, due to the potential of emerging resistance exposure and most commonly occur secondary to trauma. seen in Aeromonas species, susceptibilities should always be Although there are numerous microorganisms that can performed and antibiotics adjusted accordingly (3). It is cause skin and soft tissue infections following water important to maintain a high index of suspicion for Aeromonas exposure, this article will focus on the 5 most common infections after water exposure in fresh and brackish water bacteria. The acronym used for these bacteria--AEEVM, and to start the patient on an appropriate empiric antibiotic refers to Aeromonas species, Edwardsiella tarda, Erysipelothrix regimen immediately. rhusiopathiae, Vibrio vulnificus, and Mycobacterium marinum. EDWARDSIELLA TARDA AEROMONAS Edwardsiella tarda is part of the Enterobacteriaceae family. Aeromonas species are gram-negative rods found worldwide in It is a motile, facultative anaerobic gram-negative rod fresh and brackish water (1-3). They have also been found in that can be found worldwide in pond water, mud, and contaminated drinking, surface, and polluted water sources the intestines of marine life and land animals (5). Risk (3). Aeromonas are usually non-lactose fermenting, oxidase factors for infection include water exposure, exposure positive facultative anaerobes.
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Hantavirus Disease Were HPS Is More Common in Late Spring and Early Summer in Seropositive in One Study in the U.K
    Hantavirus Importance Hantaviruses are a large group of viruses that circulate asymptomatically in Disease rodents, insectivores and bats, but sometimes cause illnesses in humans. Some of these agents can occur in laboratory rodents or pet rats. Clinical cases in humans vary in Hantavirus Fever, severity: some hantaviruses tend to cause mild disease, typically with complete recovery; others frequently cause serious illnesses with case fatality rates of 30% or Hemorrhagic Fever with Renal higher. Hantavirus infections in people are fairly common in parts of Asia, Europe and Syndrome (HFRS), Nephropathia South America, but they seem to be less frequent in North America. Hantaviruses may Epidemica (NE), Hantavirus occasionally infect animals other than their usual hosts; however, there is currently no Pulmonary Syndrome (HPS), evidence that they cause any illnesses in these animals, with the possible exception of Hantavirus Cardiopulmonary nonhuman primates. Syndrome, Hemorrhagic Nephrosonephritis, Epidemic Etiology Hemorrhagic Fever, Korean Hantaviruses are members of the genus Orthohantavirus in the family Hantaviridae Hemorrhagic Fever and order Bunyavirales. As of 2017, 41 species of hantaviruses had officially accepted names, but there is ongoing debate about which viruses should be considered discrete species, and additional viruses have been discovered but not yet classified. Different Last Updated: September 2018 viruses tend to be associated with the two major clinical syndromes in humans, hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary (or cardiopulmonary) syndrome (HPS). However, this distinction is not absolute: viruses that are usually associated with HFRS have been infrequently linked to HPS and vice versa. A mild form of HFRS in Europe is commonly called nephropathia epidemica.
    [Show full text]
  • WHO GUIDELINES for the Treatment of Treponema Pallidum (Syphilis)
    WHO GUIDELINES FOR THE Treatment of Treponema pallidum (syphilis) WHO GUIDELINES FOR THE Treatment of Treponema pallidum (syphilis) WHO Library Cataloguing-in-Publication Data WHO guidelines for the treatment of Treponema pallidum (syphilis). Contents: Web annex D: Evidence profiles and evidence-to-decision frameworks - Web annex E: Systematic reviews for syphilis guidelines - Web annex F: Summary of conflicts of interest 1.Syphilis – drug therapy. 2.Treponema pallidum. 3.Sexually Transmitted Diseases. 4.Guideline. I.World Health Organization. ISBN 978 92 4 154980 6 (NLM classification: WC 170) © World Health Organization 2016 All rights reserved. Publications of the World Health Organization are available on the WHO website (http://www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (http://www.who.int/about/licensing/ copyright_form/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,018,158 B2 Onsoyen Et Al
    US0090181.58B2 (12) United States Patent (10) Patent No.: US 9,018,158 B2 Onsoyen et al. (45) Date of Patent: Apr. 28, 2015 (54) ALGINATE OLIGOMERS FOR USE IN 7,208,141 B2 * 4/2007 Montgomery .................. 424/45 OVERCOMING MULTIDRUG RESISTANCE 22:49 R: R388 al al W . aSOC ea. N BACTERA 7,671,102 B2 3/2010 Gaserod et al. 7,674,837 B2 3, 2010 G d et al. (75) Inventors: Edvar Onsoyen, Sandvika (NO); Rolf 7,758,856 B2 T/2010 it. Myrvold, Sandvika (NO); Arne Dessen, 7,776,839 B2 8/2010 Del Buono et al. Sandvika (NO); David Thomas, Cardiff 2006.8 R 38 8. Melist al. (GB); Timothy Rutland Walsh, Cardiff 2003/0022863 A1 1/2003 Stahlang et al. (GB) 2003/0224070 Al 12/2003 Sweazy et al. 2004/OO73964 A1 4/2004 Ellington et al. (73) Assignee: Algipharma AS, Sandvika (NO) 2004/0224922 A1 1 1/2004 King 2010.0068290 A1 3/2010 Ziegler et al. (*) Notice: Subject to any disclaimer, the term of this 2010/0305062 A1* 12/2010 Onsoyen et al. ................ 514/54 patent is extended or adjusted under 35 U.S.C. 154(b) by 184 days. FOREIGN PATENT DOCUMENTS DE 268865 A1 1, 1987 (21) Appl. No.: 13/376,164 EP O324720 A1 T, 1989 EP O 506,326 A2 9, 1992 (22) PCT Filed: Jun. 3, 2010 EP O590746 A1 4f1994 EP 1234584 A1 8, 2002 (86). PCT No.: PCT/GB2O1 O/OO1097 EP 1714660 A1 10, 2006 EP 1745705 A1 1, 2007 S371 (c)(1), FR T576 M 3/1968 (2), (4) Date: Jan.
    [Show full text]
  • Identification of Pasteurella Species and Morphologically Similar Organisms
    UK Standards for Microbiology Investigations Identification of Pasteurella species and Morphologically Similar Organisms Issued by the Standards Unit, Microbiology Services, PHE Bacteriology – Identification | ID 13 | Issue no: 3 | Issue date: 04.02.15 | Page: 1 of 28 © Crown copyright 2015 Identification of Pasteurella species and Morphologically Similar Organisms Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website https://www.gov.uk/uk- standards-for-microbiology-investigations-smi-quality-and-consistency-in-clinical- laboratories. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see https://www.gov.uk/government/groups/standards-for-microbiology-investigations- steering-committee). The contributions of many individuals in clinical, specialist and reference laboratories who have provided information and comments during the development of this document are acknowledged. We are grateful to the Medical Editors for editing the medical content. For further information please contact us at: Standards Unit Microbiology Services Public Health England 61 Colindale Avenue London NW9 5EQ E-mail: [email protected] Website: https://www.gov.uk/uk-standards-for-microbiology-investigations-smi-quality- and-consistency-in-clinical-laboratories UK Standards for Microbiology Investigations are produced in association with: Logos correct at time of publishing. Bacteriology – Identification | ID 13 | Issue no: 3 | Issue date: 04.02.15 | Page: 2 of 28 UK Standards for Microbiology Investigations | Issued by the Standards Unit, Public Health England Identification of Pasteurella species and Morphologically Similar Organisms Contents ACKNOWLEDGMENTS .........................................................................................................
    [Show full text]
  • Antibiotic Use Guidelines for Companion Animal Practice (2Nd Edition) Iii
    ii Antibiotic Use Guidelines for Companion Animal Practice (2nd edition) iii Antibiotic Use Guidelines for Companion Animal Practice, 2nd edition Publisher: Companion Animal Group, Danish Veterinary Association, Peter Bangs Vej 30, 2000 Frederiksberg Authors of the guidelines: Lisbeth Rem Jessen (University of Copenhagen) Peter Damborg (University of Copenhagen) Anette Spohr (Evidensia Faxe Animal Hospital) Sandra Goericke-Pesch (University of Veterinary Medicine, Hannover) Rebecca Langhorn (University of Copenhagen) Geoffrey Houser (University of Copenhagen) Jakob Willesen (University of Copenhagen) Mette Schjærff (University of Copenhagen) Thomas Eriksen (University of Copenhagen) Tina Møller Sørensen (University of Copenhagen) Vibeke Frøkjær Jensen (DTU-VET) Flemming Obling (Greve) Luca Guardabassi (University of Copenhagen) Reproduction of extracts from these guidelines is only permitted in accordance with the agreement between the Ministry of Education and Copy-Dan. Danish copyright law restricts all other use without written permission of the publisher. Exception is granted for short excerpts for review purposes. iv Foreword The first edition of the Antibiotic Use Guidelines for Companion Animal Practice was published in autumn of 2012. The aim of the guidelines was to prevent increased antibiotic resistance. A questionnaire circulated to Danish veterinarians in 2015 (Jessen et al., DVT 10, 2016) indicated that the guidelines were well received, and particularly that active users had followed the recommendations. Despite a positive reception and the results of this survey, the actual quantity of antibiotics used is probably a better indicator of the effect of the first guidelines. Chapter two of these updated guidelines therefore details the pattern of developments in antibiotic use, as reported in DANMAP 2016 (www.danmap.org).
    [Show full text]
  • Klebsiella Ornithinolytica
    international Journal of Systematic Bacteriology (1 999), 49, 1695-1 700 Printed in Great Britain Phylogenetic evidence for reclassification of Calymmatobacterium granulomatis as Klebsiella granulomatis comb. nov. Jenny 5. Carter,’l2 Francis J. B~wden,~Ivan Ba~tian,~Garry M. Myers,’ K. S. Sriprakash’ and David J. Kemp’ Author for correspondence : David J. Kemp. Tel : + 6 18 8922 84 12. Fax : + 6 18 8927 5 187 e-mail : [email protected] 1 Menzies School of Health By sequencing a total of 2089 bp of the 16s rRNA and phoE genes it was Research, Darwin, demonstratedthat Calymmatobacterium grandomatis (the causative Austra Iia organism of donovanosis) shows a high level of identity with Klebsiella * Centre for Indigenous species pathogenic to humans (Klebsiellapneumoniae, Klebsiella Natural and Cultural Resource Management, rhinoscleromatis). It is proposed that C. grandomatis should be reclassified as Faculty of Aboriginal and Klebsiella granulomatis comb. nov. An emended description of the genus Torres Strait Islander Klebsiella is given. Studies, Northern Territory University, Darwin, Australia 3 Institute of Medical and Keywords : Calymmatobacteriurn, Klebsiella, sequence data, phylogenetic inferences Veterinary Science, Adelaide, Australia 4 AIDS/STD Unit, Royal Darwin Hospital, Darwin, Australia Calymmatobacterium granulomatis is the presumed ganism (Richens, 1991) have prevented further char- causative agent of donovanosis, an important cause of acterization of this relationship. genital ulceration that occurs in small endemic foci in all continents except Europe and Antarctica. The name Non-cultivable pathogenic eubacteria have been C. granulomatis was originally given to the pleo- identified by PCR using primers targeting conserved morphic bacterium cultured from donovanosis lesions genes (Fredricks & Relman, 1996).
    [Show full text]
  • Retrospective Study of Aeromonas Infection in a Malaysian Urban Area: a 10-Year Experience W S Lee, S D Puthucheary
    Singapore Med J 2001 Vol 42(2) : 057-060 Original Article Retrospective Study of Aeromonas Infection in a Malaysian Urban Area: A 10-year Experience W S Lee, S D Puthucheary ABSTRACT Keywords: Aeromonas, gastroenteritis, childhood Aims: To describe the patterns of isolation of Singapore Med J 2001 Vol 42(2):057-060 Aeromonas spp. and the resulting spectrum of infection, intestinal and extra-intestinal, from infants INTRODUCTION and children in an urban area in a hot and humid A variety of human infections, including gastroenteritis, country from Southeast Asia. cellulitis, wound infections, hepatobiliary infections and Materials and methods: Retrospective review of all septicaemia have been reported to be associated with bacterial culture records from children below 16 Aeromonas spp.(1,2). At least three distinctive gastro- years of age, from the Department of Medical intestinal syndromes following gastroenteritis caused by Microbiology, University of Malaya Medical Centre, of Aeromonas sp. have been described: (a) acute, watery Kuala Lumpur, from January 1988 to December 1997. diarrhoea; (b) dysentery; and (c) subacute or chronic Review of all stool samples and rectal swabs obtained diarrhoea(3). Acute watery diarrhoea was self-limiting(4,5). from children during the same period were carried Dysentery-like illness with bloody and mucousy out to ascertain the isolation rate of Aeromonas sp. diarrhoea, mimicking childhood inflammatory bowel from stools and rectal swabs. The case records of disease was seen occasionally(3). The highest attack rate those with a positive Aeromonas culture were for Aeromonas-associated gastroenteritis appears to be retrieved and reviewed. in young children(4). A wide difference in the frequency of isolation of Aeromonas spp.
    [Show full text]